Á¦¸ñ |
¾Ç°ñ °ñ±«»ç
|
ÀÛ¼ºÀÚ |
|
ÀÛ¼ºÀÏ |
2006-09-27 |
Bisphosphonates¿Í ¾Ç°ñ °ñ±«»ç(ONJ)¿ÍÀÇ »ó°ü°ü°è´Â ¾ÆÁ÷µµ ¸»ÀÌ ¸¹Àº °Í °°½À´Ï´Ù. ÃÖ±Ù JOMI ³í¹®¿¡¼ °æ±¸¿ëÀÇ °æ¿ì¿¡´Â ONJ¿Í °ü·ÃÀÌ ¾ø´Ù°íµµ ¸»ÇÏ°í ÀÖ½À´Ï´Ù¸¸ ¿ª½Ã ÃÖ±ÙÀÇ JOMS³í¹®¿¡¼´Â ´ÙÀ½°ú °°Àº ³»¿ëÀÌ ³ª¿Í ÀÖ½À´Ï´Ù.
"¹Ì±¹ FDA¿¡ º¸°íµÈ ¾Ç°ñ °ñ±«»ç case´Â ÇöÀç±îÁö ¾à 2000¿©°ÇÀÌ µË´Ï´Ù. Á¾Á¾ ¹ßÄ¡ÇàÀ§°¡ ÀÌ ¾Ç°ñ °ñ±«»ç¸¦ À¯¹ß½ÃÅ°´Â ÀÎÀÚ°¡ µÇ±â ¶§¹®¿¡ bisphosphonates¸¦ º¹¿ëÇÏ°í Àִ ȯÀÚ´Â ¹ßÄ¡¸¦ ÇÇÇÏ´Â °ÍÀÌ ÁÁ°Ú½À´Ï´Ù. ¾Ç°ñ°ñ±«»ç¿Í °ü·ÃÀÌ ÀÖ´Â ÀÎÀÚµéÀº metastatic breast cancer, multiple myeloma, osteoporosis, history of bisphosphonate use, concurrent chemotherapy, poor dental health, smoking µîÀÌ ÀÖ½À´Ï´Ù."